Cargando…

Rat Hepatitis E in an Immunocompromised Patient

Detalles Bibliográficos
Autores principales:	Hon, Kam Lun, Sridhar, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678593/ https://www.ncbi.nlm.nih.gov/pubmed/33231190 http://dx.doi.org/10.1007/s13312-020-2051-z

Ejemplares similares

A small animal model of chronic hepatitis E infection using immunocompromised rats
por: Sridhar, Siddharth, et al.
Publicado: (2022)

Hepatitis E in immunocompromised individuals
por: Damiris, Konstantinos, et al.
Publicado: (2022)

An Opportunity to Better Understand the Impact of Coronaviruses on Immunocompromised Patients
por: Parisi, Christina
Publicado: (2020)

Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19
por: Destras, Grégory, et al.
Publicado: (2021)

The unmet need for COVID-19 treatment in immunocompromised patients
por: Alessandra, D’Abramo, et al.
Publicado: (2022)

Potential benefit of convalescent plasma transfusions in immunocompromised patients with COVID-19
por: Rodionov, Roman N, et al.
Publicado: (2021)

SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients
por: Scherer, Erin M., et al.
Publicado: (2022)

Molnupiravir efficacy among immunocompromised patients with COVID-19: no proof of concept
por: Guermazi, Dorra, et al.
Publicado: (2023)

Letter to the Editor: Emergence of Zoonotic Rat Hepatitis E Virus Infection
por: Adlhoch, Cornelia, et al.
Publicado: (2020)

Isoscartopic Response: Another Facet of the Immunocompromised Cutaneous District
por: Caccavale, Stefano, et al.
Publicado: (2016)

Challenges in Antimicrobial Stewardship: Rapid Diagnostics and Optimization of Therapy Among Immunocompromised Patients
por: Rosa, Rossana, et al.
Publicado: (2019)

Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection
por: Sun, Fangfang, et al.
Publicado: (2022)

Dermoscopy of Partially Pigmented Bowen's Disease in an Immunocompromised Patient: An Emphasis on White Rosettes
por: Ankad, Balachandra S., et al.
Publicado: (2023)

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
por: Choi, Bina, et al.
Publicado: (2020)

Staying Awake in Severe Acute Respiratory Distress Syndrome: A Perspective on Immunocompromised Patients
por: Stahl, Klaus, et al.
Publicado: (2021)

Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients
por: Destras, Grégory, et al.
Publicado: (2022)

Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients
por: Solera, Javier T, et al.
Publicado: (2023)

Radiation Port Cutaneous Metastases: A Further Example of Immunocompromised District
por: Ruocco, Eleonora, et al.
Publicado: (2014)

Chronic hepatitis E – an emerging disease in an immunocompromised host
por: Singh, Amitabh, et al.
Publicado: (2018)

Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection
por: Reuken, Philipp A., et al.
Publicado: (2021)

Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review
por: Parker, Edward P K, et al.
Publicado: (2022)

Unmet Needs for the Treatment of Chronic Hepatitis E Virus Infection in Immunocompromised Patients
por: Kamar, Nassim, et al.
Publicado: (2022)

910. Evaluation of an Enzymatic Immunoassay System for Detection and Differentiation of Rat Hepatitis E Virus Infection in Humans
por: Sridhar, Siddharth, et al.
Publicado: (2021)

Immunocompromise and durability of BNT162b2 vaccine against severe outcomes due to omicron and delta variants
por: Tartof, Sara Y, et al.
Publicado: (2022)

Phylogenetic analysis of swine & human hepatitis E virus
por: Sarangi, Aditya Narayan, et al.
Publicado: (2011)

Novel treatment combining antiviral and neutralizing antibody-based therapies with monitoring of spike-specific antibody and viral load for immunocompromised patients with persistent COVID-19 infection
por: Wada, Daiki, et al.
Publicado: (2022)

No link between the prevalence of hepatitis E virus infection and the diagnosis of schizophrenia
por: Beisel, Claudia, et al.
Publicado: (2022)

Avian hepatitis E virus infection of duck, goose, and rabbit in northwest China
por: Liu, Baoyuan, et al.
Publicado: (2018)

Cytomegalovirus Hepatitis in Immunocompetent and Immunocompromised Hosts
por: Da Cunha, Teresa, et al.
Publicado: (2021)

The Diagnosis, Pathophysiology, and Treatment of Chronic Hepatitis E Virus Infection—A Condition Affecting Immunocompromised Patients
por: Takakusagi, Satoshi, et al.
Publicado: (2023)

In Response to the Article “Computed Tomography Features of Pulmonary Nocardiosis in Immunocompromised and Immunocompetent Patients”; Pol J Radiol, 2015; 80: 13–17
por: Bhoil, Rohit
Publicado: (2015)

The Endoscopic Endonasal Dacryocystorhinostomy (eDCR) in the Immunocompromised Patient
por: Lunardi, G., et al.
Publicado: (2023)

IMMUNOPOTENTIATION BY IMMU 21 IN IMMUNOCOMPROMISED RATS
por: Chatterjee, S., et al.
Publicado: (1997)

Post Herpes Zoster Trigeminal Trophic Syndrome in a Child: An Example of Immunocompromised District
por: Caccavale, Stefano, et al.
Publicado: (2016)

Immunocompromised Patients
por: Humphreys, Hilary, et al.
Publicado: (2012)

Hepatic Cirrhosis
por: Lal, Sham Mohan
Publicado: (1905)

Hepatic Abscess
por: Smith, Henry
Publicado: (1893)

An immunoassay system to investigate epidemiology of Rocahepevirus ratti (rat hepatitis E virus) infection in humans
por: Situ, Jianwen, et al.
Publicado: (2023)

Hemodialysis Patients: a High Risk Group for Hepatitis C
por: Omar, AH, et al.
Publicado: (2008)

Increased apoptosis of regulatory T cells in patients with active autoimmune hepatitis
por: John, Katharina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4124nnqgkrlrtjc8pai9mfnem4